×
Mirabegron (50mg)

Avomira 50mg Tablet ER


Rs 390 25 % Off


Package size

  • Rs 390
  • 0 Soft gelatin Capsules

    Estimate Delivery by: Tomorrow

    Delivering to 201301, Noida


    Easy 7 days return available

    Rs 390 25 % Off

    Avomira 50mg Tablet ER

    Avomira 50mg Tablet ER is used to treat symptoms of overactive bladder that includes increased or frequent urination, urgent need to urinate and inability to control urination. It helps to relax the muscle surrounding the bladder and increase its ability to store urine. Avomira 50mg Tablet ER is advised to take it in a dose and duration as per prescription. It can be taken with or without food. Swallow the medicine as a whole without crushing or chewing it. You should not stop taking the medicine without consulting the doctor as it may lead to the worsening of your symptoms. The course of the treatment should be completed for better efficacy of the medicine. Some common side effects of this medicine are constipation, headache, high blood pressure, nasal inflammation, urinary tract infection, rapid heartbeat, and joint pain. If any of the side effects bother you or persist, consult the doctor without delay. Before receiving the treatment, inform your doctor if you are on any medication for any other health condition. If you are pregnant or breastfeeding, tell your doctor prior to the treatment. Patients with liver or kidney disease must be cautious while receiving the prescription and they must receive regular follow-ups as per the doctor’s advice.

    Product Highlights and Usage:

    Uses: Treatment of Overactive bladder (OAB) Benefits: Treatment of Overactive bladder (OAB) Avomira 50mg Tablet ER helps to treat uncontrollable contractions (spasms) of the bladder muscles that cause frequent urination, urgent need to urinate, and inability to control the passing of urine. It also relieves painful, or frequent urination and reduces the urgency to urinate that may occur with some infections of the urinary tract. This way it helps manage the overactive bladder symptoms efficiently.

    How it works:

    Avomira 50mg Tablet ER is a beta 3-receptor agonist. It works by activating the receptor in the bladder, causing the bladder muscles to relax. It prevents frequent, urgent or uncontrolled urination.

    Directions for use:

    Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Avomira 50mg Tablet ER may be taken with or without food.

    Warning & Precaution:

    Safety Advice: Alcohol: It is not known whether it is safe to consume alcohol with Avomira 50mg Tablet ER. Please consult your doctor. Pregnancy: Avomira 50mg Tablet ER is not recommended during pregnancy as there is positive evidence of fetal risk based on animal studies. However, it may still be prescribed by a doctor in situations where the benefits outweigh the risks. Breast feeding: Avomira 50mg Tablet ER should be used with caution during breastfeeding. Breastfeeding should be held until the treatment of the mother is completed and the drug is eliminated from the body. Driving: Avomira 50mg Tablet ER does not usually affect your ability to drive. Kidney: Avomira 50mg Tablet ER should be used with caution in patients with kidney disease. Dose adjustment may be needed. Liver: Avomira 50mg Tablet ER should be used with caution in patients with liver disease. Dose adjustment may be needed.
    Use of Avomira 50mg Tablet ER is not recommended in patients with severe liver disease. Side Effects: Headache | High blood pressure | Urinary tract infection | Nasopharyngitis (inflammation of the throat and nasal passages)

    4.2
    Date

    TEsa

    Lorem Ipsum is simply dummy text of the printing and typesetting industry. Lorem Ipsum has been the industry's standard dummy text ever since the 1500s

    medicare-logo-white

    APMEDCARE: Your digital partner in navigating secure, accessible healthcare services.

    Recent Posts

    Products

    Our services

    Copyright @ AXOLAB PHARMACEUTICALS PRIVATE LIMITED, 2025. All rights reserved.